| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Medical Oncology, Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC 20007; Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland 20892; and William S. Middleton Memorial Veterans Hospital, Medical Oncology Section, Madison, Wisconsin 53705
MCF-7 human breast cancer cells are estrogen dependent for maximal in vitro growth and for tumor formation in nude mice, thus providing a useful model system to study mammary tumorigenesis. A clone of MCF-7 cells transfected with the v-rasH oncogene has been shown to form tumors in the absence of estradiol [Kasid et al., 1985, Science (Wash. DC), 228: 725–728]. To extend this observation to more clones of v-rasH-expressing MCF-7 cells and to examine the effects of rasH mutation, we transfected MCF-7 cells with a construct encoding the human c-rasH protooncogene protein product and with three isogenic constructs encoding proteins containing point mutations: arg-12, thr-59, and arg-12 + thr-59 (v-rasH). We isolated several cell lines which produced levels of c-rasH and v-rasH p21 at 30- to 50-fold the levels of controls. We also isolated several cell lines producing the various mutants p21s. All of the transfected cell lines were estrogen-responsive for cell growth. Transfected cells containing high levels of rasH p21 had correspondingly high levels of growth in an anchorage-independent growth assay. Tumorigenesis studies in nude mice, however, showed that some, but not all of the cell lines expressing v-rasH, formed tumors in the absence of estradiol. Tumor formation did not correlate with the level of rasH p21 expression in these cell lines. No tumor formation in the absence of estradiol was observed for cell lines expressing single-mutated or unmutated forms of rasH.
1 To whom requests for reprints should be addressed, at Division of Medical Oncology, Lombardi Cancer Center, Georgetown University Medical Center, 3800 Reservoir Road, Washington, DC 20007.
Received 7/28/88. Revised 7/ 7/89. Accepted 10/ 2/89.
This article has been cited by other articles:
![]() |
X. Qi, J. Tang, M. Loesch, N. Pohl, S. Alkan, and G. Chen p38{gamma} Mitogen-Activated Protein Kinase Integrates Signaling Crosstalk between Ras and Estrogen Receptor to Increase Breast Cancer Invasion. Cancer Res., August 1, 2006; 66(15): 7540 - 7547. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Gadal, A Starzec, C Bozic, C Pillot-Brochet, S Malinge, V Ozanne, J Vicenzi, L Buffat, G Perret, F Iris, et al. Integrative analysis of gene expression patterns predicts specific modulations of defined cell functions by estrogen and tamoxifen in MCF7 breast cancer cells J. Mol. Endocrinol., February 1, 2005; 34(1): 61 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Gadal, C. Bozic, C. Pillot-Brochet, S. Malinge, S. Wagner, A. Le Cam, L. Buffat, M. Crepin, and F. Iris Integrated transcriptome analysis of the cellular mechanisms associated with Ha-ras-dependent malignant transformation of the human breast epithelial MCF7 cell line Nucleic Acids Res., October 1, 2003; 31(19): 5789 - 5804. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Pethe and P. V. M. Shekhar Estrogen Inducibility of c-Ha-ras Transcription in Breast Cancer Cells. IDENTIFICATION OF FUNCTIONAL ESTROGEN-RESPONSIVE TRANSCRIPTIONAL REGULATORY ELEMENTS IN EXON 1/INTRON 1 OF THE c-Ha-ras GENE J. Biol. Chem., October 22, 1999; 274(43): 30969 - 30978. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |